CSBR:NASDAQ
Champions Oncology Inc
$4.70
arrow_upward
+1.18%(+0.055) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.57
High
$4.70
Low
$4.52
Mkt. cap
65.49M
Avg. vol.
8.16K
Volume
3.02K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.57
High
$4.70
Low
$4.52
Mkt. cap
65.49M
Avg. vol.
8.16K
Volume
3.02K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
TradingView
·
36 minutes ago
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
24/7 Wall St.
·
1 hour ago
Union Pacific Beat the S&P 500 by 28.76 Points in the Past Year, and $1,000 From a Decade Ago Is Now Worth $3,693
Benzinga
·
40 minutes ago
S&P 500 Rout Exposes Hidden Risk In 10% Buffered ETFs
Traders Union
·
3 hours ago
Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com